IDEXX Laboratories Inc (IDXX)
506.56
-10.62
(-2.05%)
USD |
NASDAQ |
Sep 20, 16:00
507.99
+1.42
(+0.28%)
After-Hours: 18:22
IDEXX Laboratories Cash from Financing (Quarterly): -210.24M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -210.24M |
March 31, 2024 | -144.07M |
December 31, 2023 | -101.84M |
September 30, 2023 | -43.04M |
June 30, 2023 | -151.03M |
March 31, 2023 | -146.08M |
December 31, 2022 | -116.72M |
September 30, 2022 | -148.83M |
June 30, 2022 | -91.91M |
March 31, 2022 | -13.48M |
December 31, 2021 | -165.82M |
September 30, 2021 | -221.73M |
June 30, 2021 | -180.22M |
March 31, 2021 | -129.65M |
December 31, 2020 | 0.398M |
September 30, 2020 | -104.18M |
June 30, 2020 | -161.53M |
March 31, 2020 | 16.90M |
December 31, 2019 | -74.39M |
September 30, 2019 | -99.75M |
June 30, 2019 | -109.49M |
March 31, 2019 | -2.781M |
December 31, 2018 | -117.81M |
September 30, 2018 | -84.29M |
June 30, 2018 | -70.71M |
Date | Value |
---|---|
March 31, 2018 | -324.99M |
December 31, 2017 | -78.06M |
September 30, 2017 | -67.87M |
June 30, 2017 | -63.40M |
March 31, 2017 | 1.313M |
December 31, 2016 | -77.25M |
September 30, 2016 | -69.25M |
June 30, 2016 | -73.14M |
March 31, 2016 | -2.562M |
December 31, 2015 | -64.60M |
September 30, 2015 | -39.66M |
June 30, 2015 | -33.53M |
March 31, 2015 | 36.80M |
December 31, 2014 | 42.34M |
September 30, 2014 | -76.27M |
June 30, 2014 | -54.55M |
March 31, 2014 | -14.96M |
December 31, 2013 | -33.06M |
September 30, 2013 | -40.33M |
June 30, 2013 | -31.32M |
March 31, 2013 | 2.252M |
December 31, 2012 | -49.85M |
September 30, 2012 | -37.23M |
June 30, 2012 | -31.70M |
March 31, 2012 | -6.564M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-221.73M
Minimum
Sep 2021
16.90M
Maximum
Mar 2020
-114.36M
Average
-123.19M
Median
Cash from Financing (Quarterly) Benchmarks
Baxter International Inc | -936.00M |
ResMed Inc | -393.28M |
NovaBay Pharmaceuticals Inc | -0.492M |
Palatin Technologies Inc | 9.136M |
iBio Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 248.31M |
Cash from Investing (Quarterly) | -32.91M |
Free Cash Flow | 838.95M |
Free Cash Flow Per Share (Quarterly) | 2.578 |
Free Cash Flow to Equity (Quarterly) | 215.93M |
Free Cash Flow to Firm (Quarterly) | 218.73M |
Free Cash Flow Yield | 1.98% |